SPOTLIGHT: Stada buys Russian pharma group

German drug maker Stada has snapped up the Russian pharma group Makiz for €125 million. Already active in the Russian market through its Nizhfarm and Hemofarm units, Stada will gain access to Makiz's production and development facilities. Makiz also has some 50 off-patent products, about half of which are sold as branded drugs. Report